All In MedTech

Device Trial Radar · NCT03115983

LimiFlex Clinical Trial for the Treatment of Degenerative Spondylolisthesis With Spinal Stenosis

A Concurrently Controlled Study of the LimiFlex™ Paraspinous Tension Band in the Treatment of Lumbar Degenerative Spondylolisthesis With Spinal Stenosis

Last checked: Nov 20, 2026Latest source record: Aug 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

299

Actual

Start

Jul 17, 2017

Primary completion

Dec 30, 2025

Study completion Jan 16, 2026

Sponsor

Lead sponsor
Empirical Spine, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Biomedical Statistical Consulting; Medical Metrics Diagnostics, Inc; MCRA
First posted
Apr 14, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 25 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The LimiFlex™ Clinical Trial is a prospective, concurrently controlled, multi-center study to evaluate the safety and effectiveness of decompression and stabilization with the Empirical Spine LimiFlex™ Paraspinous Tension Band compared to decompression and transforaminal lumbar interbody fusion (TLIF) with concomitant posterolateral fusion (PLF) for the treatment of lumbar degenerative spondylolisthesis (Grade I per Meyerding classification) with spinal stenosis. Clinical trial sites will enroll solely LimiFlex subjects or solely TLIF/PLF subjects.

Conditions

  • Degenerative Spondylolisthesis
  • Lumbar Spinal Stenosis

Interventions

  • LimiFlexDevice

    LimiFlex implantation at a single level after surgical decompression.

  • Fusion InstrumentationDevice

    Titanium alloy top-loading, polyaxial pedicle screws and cylindrical, titanium alloy rod instrumentation using autograft and/or allograft bone (i.e., cancellous and/or corticocancellous bone only), and/or a synthetic bone graft extender that is on-label for these indications (i.e., decorticated posterolateral gutter only). The TLIF requires a single PEEK or Titanium TLIF cage cleared by FDA for this indication filled with autograft and/or allograft bone (i.e., cancellous and/or corticocancellous bone only).

  • DecompressionProcedure

    Surgical decompression at one or two contiguous levels from L1 to S1.

  • FusionProcedure

    Transforaminal lumbar interbody fusion (TLIF) with concomitant posterolateral fusion (PLF) at a single level after surgical decompression.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Composite Clinical SuccessTime frame: 24 Months

Locations

28 sites in 1 country. Site status is shown where the registry gives one.

  • Sonoran Spine Research and Education Foundation

    Tempe, Arizona

27 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.